Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three months ended March 31, 2025
Filing Date: May 15, 2025
Principal Office: Vancouver, British Columbia, Canada
This filing serves as a cover document submitting unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis (MD&A) for the quarter ended March 31, 2025.
Key Financial Metrics
The provided text is a cover sheet and does not contain the detailed financial data found in the attached exhibits (99.1 and 99.2). Consequently, the following metrics are not available in the source text:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Note: Specific values for these metrics are not present in the filing text provided.
Material Changes
The filing text does not provide specific data regarding material changes compared to the prior comparable period. Investors must refer to Exhibit 99.2 (MD&A) for comparative analysis.
Guidance, Outlook, and Risks
The cover document does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. These disclosures are contained within the attached exhibits (99.1 and 99.2) which are referenced but not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual unaudited interim condensed consolidated financial statements to verify revenue, expenses, and cash position.
- Review Exhibit 99.2 for Management's Discussion and Analysis to understand operational performance and material changes.
- Confirm the company's status as a foreign private issuer filing under Form 40-F (as indicated by the checkmark in the filing).
- Verify the signatures of the CEO and CFO in Exhibits 99.3 and 99.4 regarding the certification of interim filings.